Literature DB >> 30293200

Irritant Contact Dermatitis.

Sonia N Bains1, Pembroke Nash2, Luz Fonacier3,4.   

Abstract

Contact dermatitis accounts for 95% of occupational skin disorders. Irritant contact dermatitis (ICD) is often caused by cumulative exposure to weak irritants, accounting for 80% of all cases of contact dermatitis. ICD can co-exist with atopic dermatitis (AD) and allergic contact dermatitis (ACD). Patients with AD and ACD may have a lower inflammatory threshold for developing ICD. Therefore, it needs to be distinguished from lesions of AD and ACD. ICD Patients report stinging and burning in excess of pruritus. Pruritus is classically reported by patients with AD and ACD. ICD lesions are typically well-demarcated unlike AD and ACD. ICD is diagnosed by exclusion. Patients undergo testing to rule out type I and type IV hypersensitivity. Negative results suggest a diagnosis of ICD. Management consists of irritant identification and avoidance with regular emollient use. Although ICD is more common in certain occupations, genetics and environment play significant roles in its development.

Entities:  

Keywords:  Allergic contact dermatitis (ACD); Contact dermatitis; Irritant contact dermatitis (ICD); Occupational skin disease; Patch testing

Mesh:

Year:  2019        PMID: 30293200     DOI: 10.1007/s12016-018-8713-0

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  19 in total

Review 1.  The Role of Diet Modification in Atopic Dermatitis: Navigating the Complexity.

Authors:  Andrea M Rustad; Melissa A Nickles; Sara N Bilimoria; Peter A Lio
Journal:  Am J Clin Dermatol       Date:  2021-10-23       Impact factor: 7.403

2.  Bacitracin: A Causative Agent of Purpuric Allergic Contact Dermatitis.

Authors:  Aysegul Ertugrul; Emrah Utku Kabatas
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-12       Impact factor: 0.885

3.  Comparison of product safety data sheet ingredient lists with skin irritants and sensitizers present in a convenience sample of light-curing resins used in additive manufacturing.

Authors:  Lauren N Bowers; Anand C Ranpara; Katherine A Roach; Alycia K Knepp; Elizabeth D Arnold; Aleksandr B Stefaniak; M Abbas Virji
Journal:  Regul Toxicol Pharmacol       Date:  2022-05-31       Impact factor: 3.598

Review 4.  Immunological Pathomechanisms of Spongiotic Dermatitis in Skin Lesions of Atopic Dermatitis.

Authors:  Ryoji Tanei; Yasuko Hasegawa
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

Review 5.  Antibiotic Hypersensitivity Mechanisms.

Authors:  Jenana H Maker; Cassandra M Stroup; Vanthida Huang; Stephanie F James
Journal:  Pharmacy (Basel)       Date:  2019-08-27

6.  Effects of chloromethylisothiazolinone/methylisothiazolinone (CMIT/MIT) on Th2/Th17-related immune modulation in an atopic dermatitis mouse model.

Authors:  Han-Na Go; Seung-Hwa Lee; Hyun-Ju Cho; Jae-Rin Ahn; Mi-Jin Kang; So-Yeon Lee; Soo-Jong Hong
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

Review 7.  What Is New in Occupational Allergic Contact Dermatitis in the Year of the COVID Pandemic?

Authors:  Erica B Lee; Marissa Lobl; Aubree Ford; Vincent DeLeo; Brandon L Adler; Ashley Wysong
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-29       Impact factor: 4.806

Review 8.  Contact Dermatitis: Classifications and Management.

Authors:  Yan Li; Linfeng Li
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-15       Impact factor: 8.667

Review 9.  Contact dermatitis.

Authors:  Pamela L Scheinman; Marc Vocanson; Jacob P Thyssen; Jeanne Duus Johansen; Rosemary L Nixon; Kate Dear; Nina C Botto; Johanna Morot; Ari M Goldminz
Journal:  Nat Rev Dis Primers       Date:  2021-05-27       Impact factor: 52.329

10.  CXCL12/CXCR4 signaling induced itch and pain sensation in a murine model of allergic contact dermatitis.

Authors:  Wenliang Su; Jiawen Yu; Qing Liu; Lulu Ma; Yuguang Huang
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.